Medicare Enrolled

Dr. Matthew Helm, MD

MOHS-Micrographic Surgery Physician · Sherman, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
230 E SYCAMORE ST STE 305, Sherman, TX 75090
9037714613
In practice since 2013 (13 years)
NPI: 1346583150 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Helm from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Helm? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Helm

Dr. Matthew Helm is a mohs-micrographic surgery physician in Sherman, TX, with 13 years in practice. Based on federal Medicare data, Dr. Helm performed 4,752 Medicare services across 2,665 unique beneficiaries.

Between the years covered by Open Payments, Dr. Helm received a total of $4,139 from 28 pharmaceutical and/or device companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Helm is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 21% volume in TX$ $4,139 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,752
Medicare services
Top 21% in TX for mohs-micrographic surgery physician
2,665
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~366 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-142,080$5$19
Destruction of precancerous skin growth, 1550$32$183
Office visit, established patient (20-29 min)472$52$249
Destruction of skin growths (warts/lesions), 1-14284$69$316
Skin biopsy, tangential267$56$276
Office visit, established patient (10-19 min)224$29$167
New patient office visit (30-44 min)135$69$262
Biopsy of related skin growth, each additional growth112$38$136
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks98$416$1,709
Destruction of precancer skin growth, 15 or more growths75$102$486
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm63$87$377
New patient office or other outpatient visit, 15-29 minutes54$47$177
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm42$190$798
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks41$314$938
Office visit, established patient (30-39 min)41$80$355
Biopsy of ear33$45$261
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm26$156$884
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm23$117$509
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm22$111$490
Punch biopsy, first skin growth17$83$305
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm17$102$442
New patient office visit (45-59 min)17$123$377
Steroid injection (triamcinolone)16$1$19
Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm15$664$2,117
Injection into skin growth, 1-7 growths14$35$127
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm14$186$838
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,139
Total received (2018-2024)
Avg $591/year across 7 years
Top 40% in TX for mohs-micrographic surgery physician
28
Companies
183
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,804 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$335 (8.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,623
2023
$851
2022
$626
2021
$354
2020
$187
2019
$272
2018
$226

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$854
Janssen Biotech, Inc.
$377
Lilly USA, LLC
$299
Amgen Inc.
$298
Novartis Pharmaceuticals Corporation
$253
Regeneron Healthcare Solutions, Inc.
$235
SUN PHARMACEUTICAL INDUSTRIES INC.
$203
Sun Pharmaceutical Industries Inc.
$191
AbbVie, Inc.
$182
Stryker Corporation
$178
DePuy Synthes Sales Inc.
$134
PFIZER INC.
$132
Allergan, Inc.
$130
Galderma Laboratories, L.P.
$113
Almirall LLC
$88
GENZYME CORPORATION
$76
Celgene Corporation
$55
LEO Pharma Inc.
$51
E.R. Squibb & Sons, L.L.C.
$48
Dermavant Sciences, Inc.
$47
AbbVie Inc.
$42
Kerecis Limited
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Fresenius Kabi USA, LLC
$24
ConvaTec Inc.
$20
Arcutis Biotherapeutics, Inc.
$17
Genentech USA, Inc.
$16
DUSA Pharmaceuticals, Inc.
$14
Top 3 companies account for 37.0% of total payments
Associated products mentioned in payments ›
20% · ADBRY · AKLIEF · BLU-U · BOTOX · BOTOX COSMETIC · COSENTYX · CYLTEZO · DUPIXENT · EBGLYSS · EUCRISA · Erivedge · Humira · IDACIO · ILUMYA · INNOVAMATRIX AC · Kerecis Omega3 SurgiClose · Klisyri · LCP · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · MESA SPINAL SYSTEM · NA · Odomzo · Otezla · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · Seysara · Skyrizi · Sotyktu · TALTZ · TFN-ADVANCE · TREMFYA · TRIATHLON · Tremfya · VA-LCP · VTAMA · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $87 per 100 Medicare services performed
Looking for a mohs-micrographic surgery physician in Sherman?
Compare mohs-micrographic surgery physicians in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

MOHS-Micrographic Surgery Physicians within 10 mi
1
Per 100K population
0.7
County median income
$70,455
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL AT SHERMA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Helm is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Helm experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Helm performed 2,080 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Helm receive payments from pharmaceutical companies?
Yes. Dr. Helm received a total of $4,139 from 28 companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Helm's costs compare to other mohs-micrographic surgery physicians in Sherman?
Dr. Helm's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Helm) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →